Intratumoral Anti-CTLA-4 Therapy: Enhancing Efficacy While Avoiding Toxicity

Por Marabelle, Aurélien, Kohrt, Holbrook, Levy, Ronald
Publicado em 2013

New insights into the mechanism of action of immune checkpoint antibodies

Por Marabelle, Aurélien, Kohrt, Holbrook, Levy, Ronald
Publicado no Oncoimmunology (2014)

Intratumoral Immunization: A New Paradigm for Cancer Therapy

Por Marabelle, Aurélien, Kohrt, Holbrook, Caux, Christophe, Levy, Ronald
Publicado em 2014

Prime time for immune-checkpoint targeted therapy at ASCO 2015

Por Marabelle, Aurélien, Routy, Bertrand, Michels, Judith, Kroemer, Guido, Zitvogel, Laurence
Publicado no Oncoimmunology (2015)

Have lessons from past failures brought us closer to the success of immunotherapy in metastatic pancreatic cancer?

Por Brunet, Laura Rosa, Hagemann, Thorsten, Gaya, Andrew, Mudan, Satvinder, Marabelle, Aurelien
Publicado no Oncoimmunology (2015)

Overcoming therapeutic MAb resistance in agressive HER2 positive breast carcinomas by adoptive immunotherapy using optizimed effectors cells

Por Valsesia-Wittmann, Sandrine, Clemenceau, Beatrice, Jallas, Anne-Catherine, Blay, Jean-Yves, Marabelle, Aurelien, Caux, Christophe, Vie, Henri
Publicado em 2013

Tetraspanin CD81, a modulator of immune suppression in cancer and metastasis

Por Vences-Catalán, Felipe, Rajapaksa, Ranjani, Srivastava, Minu K., Marabelle, Aurelien, Kuo, Chiung-Chi, Levy, Ronald, Levy, Shoshana
Publicado no Oncoimmunology (2015)

Combination strategies to enhance antitumor ADCC

Por Kohrt, Holbrook E, Houot, Roch, Marabelle, Aurélien, Cho, Hearn Jay, Osman, Keren, Goldstein, Matthew, Levy, Ronald, Brody, Joshua
Publicado em 2012

In Vitro and In Vivo Comparison of Lymphocytes Transduced with a Human CD16 or with a Chimeric Antigen Receptor Reveals Potential Off-Target Interactions due to the IgG2 CH2-CH3 CA...

Por Clémenceau, Béatrice, Valsesia-Wittmann, Sandrine, Jallas, Anne-Catherine, Vivien, Régine, Rousseau, Raphaël, Marabelle, Aurélien, Caux, Christophe, Vié, Henri
Publicado no J Immunol Res (2015)

Detection of tumor ALK status in neuroblastoma patients using peripheral blood

Por Combaret, Valérie, Iacono, Isabelle, Bellini, Angela, Bréjon, Stéphanie, Bernard, Virginie, Marabelle, Aurélien, Coze, Carole, Pierron, Gaelle, Lapouble, Eve, Schleiermacher, Gudrun, Blay, Jean Yves
Publicado no Cancer Med (2015)

Trial watch: Tumor-targeting monoclonal antibodies for oncological indications

Por Vacchelli, Erika, Pol, Jonathan, Bloy, Norma, Eggermont, Alexander, Cremer, Isabelle, Fridman, Wolf Hervé, Galon, Jérôme, Marabelle, Aurélien, Kohrt, Holbrook, Zitvogel, Laurence, Kroemer, Guido, Galluzzi, Lorenzo
Publicado no Oncoimmunology (2015)

Sequential tumor and dual immune targeted immunotherapy: anti-lymphoma activity of Rituximab with 4-1bb stimulation and PD-1 blockade

Por Mueller, Antonia MS, Hebb, Jonathan, Sagiv-Barfi, Idit, Marabelle, Aurelien, Houot, Roch, Rajapaksa, Amanda, Czerwinski, Debra K, Chang, Serena, Chester, Cariad, Sadaram, Mohith, Waller, Erin, Levy, Ronald, Kohrt, Holbrook
Publicado no J Immunother Cancer (2014)

Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications

Por Buqué, Aitziber, Bloy, Norma, Aranda, Fernando, Castoldi, Francesca, Eggermont, Alexander, Cremer, Isabelle, Fridman, Wolf Hervé, Fucikova, Jitka, Galon, Jérôme, Marabelle, Aurélien, Spisek, Radek, Tartour, Eric, Zitvogel, Laurence, Kroemer, Guido, Galluzzi, Lorenzo
Publicado no Oncoimmunology (2015)

Prognostic impact of the expression of NCR1 and NCR3 NK cell receptors and PD-L1 on advanced non-small cell lung cancer

Por Fend, Laetitia, Rusakiewicz, Sylvie, Adam, Julien, Bastien, Bérangère, Caignard, Anne, Messaoudene, Meriem, Iribarren, Christina, Cremer, Isabelle, Marabelle, Aurélien, Borg, Christophe, Semeraro, Michaela, Barraud, Luc, Limacher, Jean-Marc, Eggermont, Alexander, Kroemer, Guido, Zitvogel, Laurence
Publicado no Oncoimmunology (2016)

Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodies

Por Kohrt, Holbrook E., Thielens, Ariane, Marabelle, Aurelien, Sagiv-Barfi, Idit, Sola, Caroline, Chanuc, Fabien, Fuseri, Nicolas, Bonnafous, Cécile, Czerwinski, Debra, Rajapaksa, Amanda, Waller, Erin, Ugolini, Sophie, Vivier, Eric, Romagné, François, Levy, Ronald, Bléry, Mathieu, André, Pascale
Publicado em 2014

Depleting tumor-specific Tregs at a single site eradicates disseminated tumors

Por Marabelle, Aurélien, Kohrt, Holbrook, Sagiv-Barfi, Idit, Ajami, Bahareh, Axtell, Robert C., Zhou, Gang, Rajapaksa, Ranjani, Green, Michael R., Torchia, James, Brody, Joshua, Luong, Richard, Rosenblum, Michael D., Steinman, Lawrence, Levitsky, Hyam I., Tse, Victor, Levy, Ronald
Publicado em 2013

Depleting tumor-specific Tregs at a single site eradicates disseminated tumors

Por Marabelle, Aurélien, Kohrt, Holbrook, Sagiv-Barfi, Idit, Ajami, Bahareh, Axtell, Robert C., Zhou, Gang, Rajapaksa, Ranjani, Green, Michael R., Torchia, James, Brody, Joshua, Luong, Richard, Rosenblum, Michael D., Steinman, Lawrence, Levitsky, Hyam I., Tse, Victor, Levy, Ronald
Publicado em 2013

The oncolytic compound LTX-401 targets the Golgi apparatus

Por Zhou, Heng, Sauvat, Allan, Gomes-da-Silva, Lígia C, Durand, Sylvère, Forveille, Sabrina, Iribarren, Kristina, Yamazaki, Takahiro, Souquere, Sylvie, Bezu, Lucillia, Müller, Kevin, Leduc, Marion, Liu, Peng, Zhao, Liwei, Marabelle, Aurélien, Zitvogel, Laurence, Rekdal, Øystein, Kepp, Oliver, Kroemer, Guido
Publicado no Cell Death Differ (2016)

Clinical Characteristics and Outcome of Patients with Neuroblastoma Presenting Genomic Amplification of Loci Other than MYCN

Por Guimier, Anne, Ferrand, Sandrine, Pierron, Gaëlle, Couturier, Jérôme, Janoueix-Lerosey, Isabelle, Combaret, Valérie, Mosseri, Véronique, Thebaud, Estelle, Gambart, Marion, Plantaz, Dominique, Marabelle, Aurélien, Coze, Carole, Rialland, Xavier, Fasola, Sylvie, Lapouble, Eve, Fréneaux, Paul, Peuchmaur, Michel, Michon, Jean, Delattre, Olivier, Schleiermacher, Gudrun
Publicado em 2014

Immunomodulatory antibodies for the treatment of lymphoma: Report on the CALYM Workshop

Por Houot, Roch, Gaulard, Philippe, Schreiber, Robert, Mellman, Ira, Lambotte, Olivier, Coulie, Pierre G., Fest, Thierry, Korman, Alan, Levy, Ronald, Shipp, Margaret, Tarte, Karin, Kohrt, Holbrook, Marabelle, Aurélien, Ansell, Stephen, Watier, Hervé, van Elsas, Andrea, Balakumaran, Arun, Arce Vargas, Frederick, Quezada, Sergio A., Salles, Gilles, Olive, Daniel
Publicado no Oncoimmunology (2016)